SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0003319708321102v1
60/3/370    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Aydin, U.
Right arrow Articles by Yasar, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aydin, U.
Right arrow Articles by Yasar, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effects of Atorvastatin on Vascular Intimal Hyperplasia: An Experimental Rodent Model

Unal Aydin, MD

Department of Cardiovascular Surgery, Bezm-I Alem Vakif Gureba Hospital, Istanbul, Turkey

Murat Ugurlucan, MD

Department of Cardiovascular Surgery, Medical Faculty, Istanbul University, Istanbul, Turkey, muratugurlucan{at}yahoo.com

Funda Gungor, MD

Obstetrics and Gynecology Clinic, State Hospital of Balikesir, Balikesir, Turkey

Sedat Ziyade, MD

Department of Cardiovascular Surgery, Bezm-I Alem Vakif Gureba Hospital, Istanbul, Turkey

Bekir Inan, MD

Department of Cardiovascular Surgery, Bezm-I Alem Vakif Gureba Hospital, Istanbul, Turkey

Maciej Banach, MD

Department of Cardiology, 1st Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Poland

Yusuf Kalko, MD

Department of Cardiovascular Surgery, Bezm-I Alem Vakif Gureba Hospital, Istanbul, Turkey

Tahsin Yasar, MD

Department of Cardiovascular Surgery, Bezm-I Alem Vakif Gureba Hospital, Istanbul, Turkey

Introduction Vascular intimal hyperplasia is associated with increased mortality and morbidity. The authors investigated the effects of atorvastatin on vascular intimal hyperplasia. Materials and methods Rats were divided into 4 groups. Groups 1, 2, and 3 had experimental aortic injury and received intraperitoneal injection of atorvastatin, solvent, or 0.9% NaCl, respectively. Group 4 was a nonintervention (laparotomy only) control group. Animals were sacrificed after 3 weeks. Blood samples and injured aortic segment were analyzed. Results Atorvastatin administration significantly lowered total and low-density lipoprotein cholesterol levels (P = .012 and P = .001, respectively), intima—media ratio (P = .002), and intimal smooth muscle cell accumulation (P < .05) in group 1. Luminal narrowing in animals in group 1 was significantly lower than that in animals in groups 2 and 3, but was higher than in animals in group 4 (P = .009). Conclusions Atorvastatin suppresses intimal hyerplasia and aids in intimal regeneration by lowering blood lipids and intimal smooth muscle cell accumulation.

Key Words: aorta • intimal hyperplasia • statin

This version was published on June 1, 2009

Angiology, Vol. 60, No. 3, 370-377 (2009)
DOI: 10.1177/0003319708321102


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement